Company
Erbe
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
22
510(k), De Novo and PMA
Device trials
7
As lead sponsor, any status
Adverse event reports
257
Received Nov 1, 2025 to Nov 19, 2026
Recall records
7
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Erbe, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Erbe.
Latest FDA decisions
The 8 newest of 22 since 2015.
K261806 · Decided Jun 9, 2026 · 8 days after receipt
Device type: Unit, Cryosurgical, Accessories (GEH) · General & Plastic Surgery
- ERBECRYO 2 Cryosurgical Unit and Accessories: ERBECRYO 2 cryosurgical unit; Erbe Flexible Cryoprobe510(k)
K253230 · Decided Apr 22, 2026 · 205 days after receipt
Device type: Unit, Cryosurgical, Accessories (GEH) · General & Plastic Surgery
K253915 · Decided Dec 18, 2025 · 10 days after receipt
Device type: Electrosurgical, Cutting & Coagulation & Accessories (GEI) · General & Plastic Surgery
19 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT07065214 · 72 participants (planned) · Start Nov 26, 2025 · Primary completion Nov 1, 2028
Device: APC; Lap bipolar forceps · For: Endometriosis
Sites: Tübingen, Germany
NCT05574777 · 13 participants · Start Apr 13, 2023 · Primary completion Aug 22, 2025
Device: Hybrid Argonplasma coagulation (HAPC) · For: Adiposity; Morbid; Obesity
Sites: São Paulo, Brazil
NCT05486338 · 15 participants · Start Sep 5, 2023 · Primary completion Jul 18, 2025
Device: Hybrid Argon Plasma Coagulation (HAPC) · For: Obesity; Adiposity
Sites: Jacksonville, Florida; Cary, North Carolina
4 more trials with a free account
Reports received
257
Received Nov 1, 2025 to Nov 19, 2026. Includes 1 of another or unstated type.
Malfunction reports
175
68% of reports
Injury reports
76
30% of reports
Death reports
5
1.9% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 1 | 6 | 0 | 0 |
| Jan 24 | 1 | 5 | 2 | 0 |
| Feb 24 | 3 | 7 | 1 | 0 |
| Mar 24 | 2 | 6 | 0 | 0 |
| Apr 24 | 1 | 4 | 0 | 0 |
| May 24 | 0 | 2 | 0 | 0 |
| Jun 24 | 2 | 6 | 0 | 0 |
| Jul 24 | 1 | 5 | 1 | 0 |
| Aug 24 | 2 | 6 | 0 | 0 |
| Sep 24 | 4 | 4 | 0 | 0 |
| Oct 24 | 4 | 6 | 0 | 0 |
| Nov 24 | 4 | 2 | 0 | 0 |
| Dec 24 | 0 | 7 | 0 | 0 |
| Jan 25 | 0 | 4 | 0 | 0 |
| Feb 25 | 2 | 7 | 0 | 0 |
| Mar 25 | 1 | 2 | 0 | 0 |
| Apr 25 | 1 | 5 | 0 | 0 |
| May 25 | 5 | 5 | 0 | 0 |
| Jun 25 | 1 | 6 | 1 | 0 |
| Jul 25 | 4 | 11 | 1 | 0 |
| Aug 25 | 3 | 3 | 0 | 0 |
| Sep 25 | 3 | 4 | 0 | 0 |
| Oct 25 | 5 | 6 | 0 | 0 |
| Nov 25 | 7 | 2 | 0 | 0 |
| Dec 25 | 16 | 8 | 0 | 0 |
| Jan 26 | 21 | 2 | 0 | 0 |
| Feb 26 | 20 | 6 | 0 | 0 |
| Mar 26 | 21 | 4 | 1 | 0 |
| Apr 26 | 32 | 9 | 0 | 0 |
| May 26 | 17 | 8 | 0 | 0 |
| Jun 26 | 16 | 8 | 2 | 0 |
| Jul 26 | 11 | 10 | 0 | 0 |
| Aug 26 | 4 | 5 | 2 | 1 |
| Sep 26 | 8 | 7 | 0 | 0 |
| Oct 26 | 2 | 7 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- ERBECRYO 2 Cryosurgical Unit Model/Catalog Number: 10402-000Open, Classified
Z-2938-2026 · Started Jun 26, 2026 · Posted by FDA Aug 12, 2026
Reason given: A strong pull on the high-pressure transfer hose of cryosurgical unit may lead to pneumatic short circuit between he gas inlet and the connector resulting in CO2 leaking into the return path, leading to excessive pressure causing the cryoprobe to rupture.
Cause as FDA categorized it: Device Design · Device type: Unit, Cryosurgical, Accessories (GEH)
Z-2062-2026 · Started Mar 31, 2026 · Posted by FDA May 1, 2026
Reason given: Devices providing sterile water/CO2/air to endoscopes were manufactured with a distal irrigation segment connector configuration that may be more susceptible to unintended water flow from distal tip under unsupported third-party connector use conditions, which may lead to water aspiration, which may progress to...
Cause as FDA categorized it: Component change control · Device type: Pump, Air, Non-Manual, For Endoscope (FEQ)
Z-2063-2026 · Started Mar 31, 2026 · Posted by FDA May 1, 2026
Reason given: Devices providing sterile water/CO2/air to endoscopes were manufactured with a distal irrigation segment connector configuration that may be more susceptible to unintended water flow from distal tip under unsupported third-party connector use conditions, which may lead to water aspiration, which may progress to...
Cause as FDA categorized it: Component change control · Device type: Endoscopic Irrigation/Suction System (OCX)
4 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.